Cambrian Biopharma

6 Decision Makers · 7 Verified Contacts & Email Format

📍 New York, NYFinance & Banking🗓 Est. 2019👥 11–50 employees

About Cambrian Biopharma

Cambrian is a distributed development company building therapeutics to lengthen health span.

Email Format

{first_name}.{last_name}@cambrianbio.com — 100.0%

sarah.smith@cambrianbio.com

Leadership & Decision Makers

Contact details of 6 Cambrian Biopharma decision makers

Ruth Thieroff-Ekerdt

EVP, Clinical Development
  • Work email

    r******************t@cambrianbio.com

Erik Schneider

Director Of Business Development LinkedIn
  • Work email

    e************r@cambrianbio.com

James Peyer

Founder and CEO

Christian Angermayer

Co-Founder

Adrienne Hallett

Vice-President of Global Policy

Sebastian Brunemeier

Founder

Team & Specialists

Contact details of 1 Cambrian Biopharma team members

Daisy Robinton

Scientist in Residence

General Emails

General company emails, e.g. customer support lines

    press@cambrianbio.com

    General Press Inquiries

    Press@cambrianbio.com

    General Press Inquiries

    jack@cambrianbio.com

    Unclassified inbox

    rosa@cambrianbio.com

    Unclassified inbox

    bd@cambrianbio.com

    Unclassified inbox

Similar Companies like Cambrian Biopharma

Finance & Banking · New York, NY · Est. 2001 · 11–50 employees

HQ: New York, NY

Finance & Banking · New York, NY · Est. 1985 · Under 10 employees · $500M–$1B

HQ: New York, NY

PJT Partners

pjtpartners.com
Finance & Banking · New York, NY · Est. 2015 · 501–1000 employees

HQ: New York, NY

Jefferies

jefferies.com
Finance & Banking · New York, NY · Est. 1962 · 1001–5000 employees

HQ: New York, NY

Explore similar firms in the Finance & Banking sector

Company Info

Last updated: 27/07/2025

(516) 962-3186

New York, NY

Legal Name: Cambrian BioPharma, Inc.
Employees: 11-50
Founded Date: 2019
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
Last Funding Type: Secondary Market
Phone Number: (516) 962-3186
Last Investment Activity: Dec 14, 2023
Investments Activity: Dec 14, 2023 Oct 17, 2023 Jul 26, 2023
Early-Stage Investments: Yes

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.